lifarizine has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bechtel, WD; Carter, AJ; Grauert, M; Nar, H; Stransky, W; Weiser, T | 1 |
| Spedding, M | 1 |
2 other study(ies) available for lifarizine and Apoplexy
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.
Topics: Animals; Benzomorphans; Cerebral Cortex; Corpus Striatum; Crystallography, X-Ray; Electroshock; Glutamic Acid; In Vitro Techniques; Male; Mice; Neuroprotective Agents; Radioligand Assay; Rats; Seizures; Sodium Channel Blockers; Stroke; Structure-Activity Relationship; Thromboembolism; Veratridine | 2002 |
Reasons why stroke trials underestimate the neuroprotective effects of drugs.
Topics: Acute Disease; Aged; Animals; Carbohydrates; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Imidazoles; Ischemia; Models, Biological; Neuroprotective Agents; Patient Selection; Piperazines; Research Design; Stroke; Time Factors | 2002 |